To date, there has been a considerable body of evidence that links the YAP/TAZ oncogene to tumorigenicity in several solid types of cancers, including ovary, breast, prostate, liver, and lung [7], [9], [12], [15]. This evidence concerns the gene YAP1 and cancer.